Proposed REX Retail Offer | 09-May-2024 | 16:49 | RNS |
Proposed Fundraise for a minimum of £6.0 mi... | 09-May-2024 | 16:48 | RNS |
Clinical Trial Agreement | 24-Apr-2024 | 15:36 | RNS |
Application for Listing & Total Voting Rights | 03-Apr-2024 | 17:00 | RNS |
NICE recommends the Genedrive CYP2C19-ID Kit | 03-Apr-2024 | 07:00 | RNS |
Half-year Report | 28-Mar-2024 | 07:00 | RNS |
Application for Listing & Total Voting Rights | 19-Mar-2024 | 15:53 | RNS |
Receipt of R&D tax credit | 15-Mar-2024 | 12:30 | RNS |
NICE Early Value Assessment update | 19-Feb-2024 | 07:00 | RNS |
Director/PDMR Shareholding | 06-Feb-2024 | 14:03 | RNS |
Total Voting Rights | 02-Feb-2024 | 15:35 | RNS |
Total Voting Rights | 19-Jan-2024 | 16:14 | RNS |
Total Voting Rights | 15-Jan-2024 | 15:21 | RNS |
Total Voting Rights | 10-Jan-2024 | 07:00 | RNS |
Equity Prepayment Facility drawdown | 02-Jan-2024 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 3.50p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 22.25 |
52 Week Low | 3.13 |
Volume | 2,820,795 |
Shares Issued | 143.14m |
Market Cap | £5.01m |
RiskGrade | 747 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:21 | 34,325 @ 3.40p |
16:21 | 173,913 @ 3.45p |
16:20 | 151,745 @ 3.30p |
16:18 | 289,855 @ 3.45p |
16:13 | 10,000 @ 3.30p |
You are here: research